Scarica l'app Stockscreener
13.78
0.79%
-0.11
Dopo l'orario di chiusura:
13.78
Theravance Biopharma Inc Azioni (TBPH) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
29.91%
19.99
|
15.39 | 18.75 | 16.87 | 14.26 |
Operating Expenses
|
11.32%
26.45
|
29.82 | 27.95 | 27.70 | 29.96 |
| Benefits Costs and Expenses |
22.51%
22.88
|
29.53 | - | - | - |
| Costs And Expenses |
22.51%
22.88
|
29.53 | 27.95 | 27.70 | 29.96 |
| Operating Income/Loss |
55.28%
-6.455
|
-14.43 | -9.20 | -10.84 | -15.71 |
| Income/Loss From Continuing Operations Before Tax |
79.57%
-2.889
|
-14.14 | 18.75 | -10.05 | -15.22 |
| Income Tax Expense/Benefit |
1,064%
-6.504
|
-0.559 | 6.588 | 2.646 | 1.308 |
| Income/Loss From Continuing Operations After Tax |
126.62%
3.615
|
-13.58 | -15.53 | -12.70 | -16.53 |
|
Net Income/Loss
|
126.62%
3.615
|
-13.58 | -15.53 | -12.70 | -16.53 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.64%
50.52
|
49.71 | 0.157 | 49.04 | 48.75 |
| Diluted Average Shares |
4.43%
51.91
|
49.71 | 0.157 | 49.04 | 48.75 |
| Basic Earnings Per Share |
125.93%
0.07
|
-0.27 | -0.31 | -0.26 | -0.34 |
| Diluted Earnings Per Share |
125.93%
0.07
|
-0.27 | -0.31 | -0.26 | -0.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):